Jennifer Weuve

a research and faculty member profile

How many people in the U.S. have Alzheimer disease when they die?

Weuve J, Hebert LE, Scherr PA, Evans DA. Deaths in the United States among persons with Alzheimer’s disease dementia (2010-2050). Alzheimer’s & Dementia 2014;10:e40-e46.

(Source: sciencedirect.com)

Postmenopausal hormone therapy and dementia: unexpected meta-analytical findings.

O’Brien J, Jackson JW, Grodstein F, Blacker D*, Weuve J*.  Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer’s disease: a new systematic review and meta-analysis of prospective observational and trial data. Epidemiologic Reviews 2014;36(1):83-103.  *contributed equally.

(Source: epirev.oxfordjournals.org)

Alzheimer disease in the U.S.: now through 2050.

Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 2013 May 7;80(19):1778-1783.

Selected related stories

Alzheimer’s rates expected to triple by 2050 because of aging baby boomers (CBS News)

Number of Americans With Alzheimer’s May Triple by 2050 (HealthDay)

An Alzheimer’s ‘epidemic’ could hit the USA by 2050 (USA TODAY)

(Source: neurology.org)

The red blood cell distribution width and prevalent dementia.

Weuve J, Mendes de Leon CF, Bennett DA, Dong X, Evans DA. The red cell distribution width and anemia in relation to prevalent dementia. Alzheimer Disease & Associated Disorders (in press).

(Source: ncbi.nlm.nih.gov)

Diabetes and Alzheimer disease.

A summary and meta-analysis of epidemiologic studies of diabetes, glucose and insulin measures in relation to Alzheimer disease.  Credits:  Sajeev G*, Weuve J*, McQueen MB, Blacker D.
* contributed equally.

Inflammatory markers in blood in relation to dementia risk.

Koyama A, O’Brien J, Weuve J, Blacker D, Metti AL, Yaffe K. The role of peripheral inflammatory markers in dementia and Alzheimer’s disease: a meta-analysis. J Gerontol A Biol Sci Med Sci 2013 Apr;68(4):433-440.

(Source: ncbi.nlm.nih.gov)

Obesity and risk of Alzheimer disease.

A summary of epidemiologic studies of overweight, obesity, and central adiposity in relation to risk of Alzheimer disease dementia.  Credits: Goonesekera S, Weuve J, Li S, Blacker D.

Head injury and risk of Alzheimer disease.

A summary of epidemiologic studies of alcohol intake and risk of Alzheimer disease dementia.  Credits: Koyama A, Weuve J, Blacker D.

Alcohol intake and risk of Alzheimer disease.

A summary of epidemiologic studies of alcohol intake and risk of Alzheimer disease dementia.  Credits: James BD, Weuve J, Blacker D.

Postmenopausal hormone use and risk of Alzheimer disease.

A summary of epidemiologic studies of use of postmenopausal hormones and risk of Alzheimer disease dementia.  Credits: O’Brien J, Weuve J, Blacker D.

See news item and commentary.

Homocysteine and risk of Alzheimer disease

A summary of epidemiologic studies of plasma homocysteine and risk of Alzheimer disease.  Credits: Li S*, Goonesekera S*, Weuve J, Blacker D.

*contributed equally

Blood pressure/hypertension and Alzheimer disease, on AlzRisk.

A summary of epidemiologic studies of blood pressure and hypertension in relation to risk of Alzheimer disease.  Credits: Power MC, Weuve J, Gagne J, McQueen MB, Viswanathan A, Blacker D.

See news item and commentary.

See the accompanying paper.

Nutritional antioxidants and risk of Alzheimer disease.

A summary of epidemiologic studies of nutritional antioxidants (vitamins C and E) and risk of Alzheimer disease.  Credits: Koyama A*, Weuve J*, Ray M, McQueen MB, Blacker D.

*contributed equally

Blood pressure and risk of Alzheimer disease, in Epidemiology.

Power MC, Weuve J, Gagne JJ, McQueen MB, Viswanathan A, Blacker D. The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology 2011 22(5):646-659.

See the complementary entry on AlzRisk here.

(Source: journals.lww.com)

Biomarkers of inflammation and Alzheimer disease.

A summary of epidemiologic studies of inflammatory biomarkers and risk of Alzheimer disease.  Credits: O’Brien J, Weuve J, Blacker D.